Ista Pharmaceuticals Inc (ISTA)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

50 TECHNOLOGY DRIVE IRVINE, CA 92618

Discovers, develops and markets new remedies for diseases and conditions of the eye. The company has launched in the United States its first product, Istalol for the treatment of glaucoma, and its second product, Vitrase for use as a spreading agent.

View SEC Filings from ISTA instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ISTA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ISTA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ANIDO VICENTE JR PRESIDENT & CEO

  • Officer
  • Director
No longer subject to file 2012-06-06 0

SILVERNAIL LAUREN P CFO & VP CORPORATE DEVELOPMENT

  • Officer
No longer subject to file 2012-06-06 0

MCGINLEY KATHLEEN VP, HR AND CORP. SERVICES

  • Officer
No longer subject to file 2012-06-06 0

MCMULLIN KIRK VP, OPERATIONS

  • Officer
No longer subject to file 2012-06-06 0

WILLIAMS RICHARD C

  • Director
No longer subject to file 2012-06-06 0

ROE WAYNE I

  • Director
No longer subject to file 2012-06-06 0

MCGRAW BENJAMIN F III

  • Director
No longer subject to file 2012-06-06 0

PERLMAN ANDREW J

  • Director
No longer subject to file 2012-06-06 0

MITCHELL DEAN J

  • Director
No longer subject to file 2012-06-06 0

HUTT PETER BARTON

  • Director
No longer subject to file 2012-06-06 0

MITRO THOMAS A VP, SALES & MARKETING

  • Officer
No longer subject to file 2012-06-06 0

MCNAMARA TIMOTHY VP CLINICAL RESEARCH & MEDICAL

  • Officer
No longer subject to file 2012-06-06 0

GARRETT MARVIN J VICE PRESIDENT, QC, COMPLIANCE

  • Officer
No longer subject to file 2012-06-06 0

DRAZBA BRIAN G. VP, FINANCE & CAO

  • Officer
No longer subject to file 2012-06-06 0

DAVIS GLENN EUGENE VP LEGAL, CHIEF COMPL. OFFICER

  • Officer
No longer subject to file 2012-06-06 0

CREDIT SUISSE AG/

  • 10% Owner
No longer subject to file 2012-03-21 0

FLYNN JAMES E

DEERFIELD CAPITAL LP

DEERFIELD PARTNERS, LP

DEERFIELD MANAGEMENT CO /NY

DEERFIELD INTERNATIONAL LTD

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD

DEERFIELD PRIVATE DESIGN FUND L P

DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
4,922,609 2011-05-04 0

LAPORTE KATHLEEN

  • Director
7,109,096 2011-04-13 0

FLYNN JAMES E

DEERFIELD MANAGEMENT CO /NY

DEERFIELD INTERNATIONAL LTD

  • 10% Owner
  • POSSIBLE MEMBERS OF 10% GROUPPOSSIBLE MEMBERS OF 10% GROUP
No longer subject to file 2008-09-25 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments